Ordeniza, Juncris P.
HRN: 20-79-98 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
OXACILLIN 500MG (VIAL)
01/01/2024
01/08/2024
IV
300mg
Q6hours
Infected Colostomy Stump
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes